Insider Buy/Sell Details for the Biotechnology Industry — February 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (106)
Aurinia Pharmaceuticals Inc. (AUPH)
TANG KEVIN — Director
Shares
1,600
Price
$14.38
Total Value
$23.01K
Shares Held After
11,845,939
% of Holdings
0.0%
Aurinia Pharmaceuticals Inc. (AUPH)
TANG KEVIN — Director
Shares
214,839
Price
$14.12
Total Value
$3.03M
Shares Held After
11,844,339
% of Holdings
1.8%
Aurinia Pharmaceuticals Inc. (AUPH)
TANG KEVIN — Director
Shares
300,000
Price
$13.90
Total Value
$4.17M
Shares Held After
11,629,500
% of Holdings
2.6%
ZIVO Bioscience, Inc. (ZIVO)
YALDOO LAITH L — Director
Shares
1,543
Price
$9.72
Total Value
$15.00K
Shares Held After
583,615
% of Holdings
0.3%
Absci Corp (ABSI)
Pangalos Menelas N — Director
Shares
75,095
Price
$2.74
Total Value
$205.76K
Shares Held After
189,055
% of Holdings
39.7%
Edesa Biotech, Inc. (EDSA)
Nijhawan Pardeep — Director
Shares
30,000
Price
$2.22
Total Value
$66.70K
Shares Held After
371,702
% of Holdings
8.1%
Larimar Therapeutics, Inc. (LRMR)
Hamilton Thomas Edward — Director
Shares
100,000
Price
$5.00
Total Value
$500.00K
Shares Held After
664,798
% of Holdings
15.0%
Larimar Therapeutics, Inc. (LRMR)
Flynn James E — Director
Shares
2,000,000
Price
$5.00
Total Value
$10.00M
Shares Held After
6,207,982
% of Holdings
32.2%
Larimar Therapeutics, Inc. (LRMR)
Flynn James E — Director
Shares
831,978
Price
$5.00
Total Value
$4.16M
Shares Held After
8,153,107
% of Holdings
10.2%
Larimar Therapeutics, Inc. (LRMR)
Flynn James E — Director
Shares
1,084,012
Price
$5.00
Total Value
$5.42M
Shares Held After
10,622,957
% of Holdings
10.2%
Larimar Therapeutics, Inc. (LRMR)
Flynn James E — Director
Shares
1,084,010
Price
$5.00
Total Value
$5.42M
Shares Held After
10,622,928
% of Holdings
10.2%
Larimar Therapeutics, Inc. (LRMR)
SHERMAN JEFFREY W — Director
Shares
5,000
Price
$5.00
Total Value
$25.00K
Shares Held After
5,000
% of Holdings
100.0%
Larimar Therapeutics, Inc. (LRMR)
THOMAS FRANK E — Director
Shares
5,000
Price
$5.00
Total Value
$25.00K
Shares Held After
7,000
% of Holdings
71.4%
AbCellera Biologics Inc. (ABCL)
Thermopylae Holdings Ltd. — 10% Owner
Shares
38,000
Price
$3.44
Total Value
$130.72K
Shares Held After
56,134,097
% of Holdings
0.1%
FibroBiologics, Inc. (FBLG)
GARCIA RUBEN A — General Counsel
Shares
40,000
Price
$0.33
Total Value
$13.06K
Shares Held After
180,000
% of Holdings
22.2%
PALVELLA THERAPEUTICS, INC. (PVLA)
HERON ELAINE J — Director
Shares
2,400
Price
$125.00
Total Value
$300.00K
Shares Held After
47,812
% of Holdings
5.0%
PALVELLA THERAPEUTICS, INC. (PVLA)
JENKINS GEORGE M — Director
Shares
4,000
Price
$125.00
Total Value
$500.00K
Shares Held After
187,171
% of Holdings
2.1%
AbCellera Biologics Inc. (ABCL)
Booth Andrew — Chief Financial Officer
Shares
42,600
Price
$3.42
Total Value
$145.69K
Shares Held After
195,600
% of Holdings
21.8%
Edesa Biotech, Inc. (EDSA)
Brooks Michael J — President
Shares
2,000
Price
$1.57
Total Value
$3.14K
Shares Held After
226,870
% of Holdings
0.9%
Edesa Biotech, Inc. (EDSA)
Nijhawan Pardeep — Director
Shares
20,571
Price
$1.58
Total Value
$32.48K
Shares Held After
615,797
% of Holdings
3.3%
Bicara Therapeutics Inc. (BCAX)
RA CAPITAL MANAGEMENT, L.P. — Director
Shares
300,000
Price
$16.00
Total Value
$4.80M
Shares Held After
4,603,418
% of Holdings
6.5%
AbCellera Biologics Inc. (ABCL)
Thermopylae Holdings Ltd. — 10% Owner
Shares
177,457
Price
$3.27
Total Value
$580.28K
Shares Held After
56,096,097
% of Holdings
0.3%
LEXICON PHARMACEUTICALS, INC. (LXRX)
DEBBANE RAYMOND — Director
Shares
2,000
Price
$1.49
Total Value
$2.98K
Shares Held After
1,906,186
% of Holdings
0.1%
Cocrystal Pharma, Inc. (COCP)
FROST PHILLIP MD ET AL — Director
Shares
20,000
Price
$1.00
Total Value
$19.95K
Shares Held After
1,908,551
% of Holdings
1.0%
Candel Therapeutics, Inc. (CADL)
Manning Paul B — Director
Shares
550,458
Price
$5.45
Total Value
$3.00M
Shares Held After
2,763,527
% of Holdings
19.9%
LEXICON PHARMACEUTICALS, INC. (LXRX)
DEBBANE RAYMOND — Director
Shares
100,000
Price
$1.47
Total Value
$147.00K
Shares Held After
1,904,186
% of Holdings
5.3%
OCULAR THERAPEUTIX, INC (OCUL)
LINDSTROM RICHARD L MD — Director
Shares
60,229
Price
$7.66
Total Value
$461.35K
Shares Held After
246,933
% of Holdings
24.4%
ARDELYX, INC. (ARDX)
MOTT DAVID M — Director
Shares
333,333
Price
$5.84
Total Value
$1.95M
Shares Held After
3,302,918
% of Holdings
10.1%
LEXICON PHARMACEUTICALS, INC. (LXRX)
DEBBANE RAYMOND — Director
Shares
100,000
Price
$1.48
Total Value
$147.79K
Shares Held After
1,804,186
% of Holdings
5.5%
MapLight Therapeutics, Inc. (MPLT)
Pavlov George — Director
Shares
9,920
Price
$17.86
Total Value
$177.17K
Shares Held After
25,000
% of Holdings
39.7%
ProMIS Neurosciences Inc. (PMN)
Kaplan Johanne — Chief Development Officer
Shares
1,629
Price
$15.35
Total Value
$25.01K
Shares Held After
3,941
% of Holdings
41.3%
LEXICON PHARMACEUTICALS, INC. (LXRX)
DEBBANE RAYMOND — Director
Shares
50,000
Price
$1.44
Total Value
$71.97K
Shares Held After
1,704,186
% of Holdings
2.9%
MapLight Therapeutics, Inc. (MPLT)
Pavlov George — Director
Shares
4,422
Price
$17.57
Total Value
$77.69K
Shares Held After
15,080
% of Holdings
29.3%
MapLight Therapeutics, Inc. (MPLT)
Pavlov George — Director
Shares
10,658
Price
$17.48
Total Value
$186.30K
Shares Held After
10,658
% of Holdings
100.0%
LEXICON PHARMACEUTICALS, INC. (LXRX)
DEBBANE RAYMOND — Director
Shares
133,688
Price
$1.32
Total Value
$176.47K
Shares Held After
1,654,186
% of Holdings
8.1%
Dermata Therapeutics, Inc. (DRMA)
Bedoya-Toro Munera Maria E — SVP, Regulatory Affairs
Shares
1,000
Price
$1.27
Total Value
$1.27K
Shares Held After
1,012
% of Holdings
98.8%
LEXICON PHARMACEUTICALS, INC. (LXRX)
DEBBANE RAYMOND — Director
Shares
76,857
Price
$1.31
Total Value
$100.54K
Shares Held After
1,520,498
% of Holdings
5.1%
LEXICON PHARMACEUTICALS, INC. (LXRX)
DEBBANE RAYMOND — Director
Shares
57,952
Price
$1.31
Total Value
$75.88K
Shares Held After
1,443,641
% of Holdings
4.0%
Sol-Gel Technologies Ltd. (SLGL)
Opaleye Management Inc. — 10% Owner
Shares
291
Price
$63.00
Total Value
$18.33K
Shares Held After
450,335
% of Holdings
0.1%
Zenas BioPharma, Inc. (ZBIO)
Allen Patricia L — Director
Shares
4,160
Price
$26.36
Total Value
$109.66K
Shares Held After
19,860
% of Holdings
20.9%
Entera Bio Ltd. (ENTX)
Rubin Steven D — Director
Shares
5,000
Price
$1.49
Total Value
$7.45K
Shares Held After
15,000
% of Holdings
33.3%
ZIVO Bioscience, Inc. (ZIVO)
STROME MARK E — 10% Owner
Shares
20,000
Price
$9.77
Total Value
$195.40K
Shares Held After
472,942
% of Holdings
4.2%
Zenas BioPharma, Inc. (ZBIO)
Allen Patricia L — Director
Shares
5,000
Price
$26.50
Total Value
$132.50K
Shares Held After
15,700
% of Holdings
31.8%
Zenas BioPharma, Inc. (ZBIO)
Allen Patricia L — Director
Shares
5,700
Price
$24.34
Total Value
$138.74K
Shares Held After
10,700
% of Holdings
53.3%
Zenas BioPharma, Inc. (ZBIO)
Allen Patricia L — Director
Shares
5,000
Price
$23.77
Total Value
$118.85K
Shares Held After
5,000
% of Holdings
100.0%
Neuraxis, INC (NRXS)
Hannasch Brian — 10% Owner
Shares
40,000
Price
$4.92
Total Value
$196.80K
Shares Held After
1,211,522
% of Holdings
3.3%
Surrozen, Inc./DE (SRZN)
TCG Crossover GP II, LLC — 10% Owner
Shares
546
Price
$23.86
Total Value
$13.03K
Shares Held After
651,112
% of Holdings
0.1%
Surrozen, Inc./DE (SRZN)
TCG Crossover GP II, LLC — 10% Owner
Shares
547
Price
$23.86
Total Value
$13.05K
Shares Held After
651,114
% of Holdings
0.1%
ONCOLYTICS BIOTECH INC (ONCY)
Andrews Patricia S — Director
Shares
35,400
Price
$0.86
Total Value
$30.29K
Shares Held After
78,128
% of Holdings
45.3%
ONCOLYTICS BIOTECH INC (ONCY)
Hagerman Allison — VP, Product Development
Shares
10,000
Price
$0.83
Total Value
$8.30K
Shares Held After
115,059
% of Holdings
8.7%
Showing 1–50 of 106 transactions (page 1 of 3)